Mylan Won't Appeal 3rd Circ. Loss On Doryx Generic
Generic-drug maker Mylan Pharmaceuticals Inc. won't be appealing the Third Circuit's decision affirming a Pennsylvania federal court's dismissal of the company's antitrust suit alleging Warner Chilcott restrained competition for acne medication...To view the full article, register now.
Already a subscriber? Click here to view full article